Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Reciprocal interplay between thyroid hormone and microRNA-21 regulates hedgehog pathway–driven skin tumorigenesis
Daniela Di Girolamo, … , Domenico Salvatore, Monica Dentice
Daniela Di Girolamo, … , Domenico Salvatore, Monica Dentice
Published May 9, 2016
Citation Information: J Clin Invest. 2016;126(6):2308-2320. https://doi.org/10.1172/JCI84465.
View: Text | PDF
Research Article Oncology

Reciprocal interplay between thyroid hormone and microRNA-21 regulates hedgehog pathway–driven skin tumorigenesis

  • Text
  • PDF
Abstract

The thyroid hormone–inactivating (TH-inactivating) enzyme type 3 iodothyronine deiodinase (D3) is an oncofetal protein that is rarely expressed in adult life but has been shown to be reactivated in the context of proliferation and neoplasms. D3 terminates TH action within the tumor microenvironment, thereby enhancing cancer cell proliferation. However, the pathological role of D3 and the contribution of TH metabolism in cancer have yet to be fully explored. Here, we describe a reciprocal regulation between TH action and the cancer-associated microRNA-21 (miR21) in basal cell carcinoma (BCC) skin tumors. We found that, besides being negatively regulated by TH at the transcriptional level, miR21 attenuates the TH signal by increasing D3 levels. The ability of miR21 to positively regulate D3 was mediated by the tumor suppressor gene GRHL3, a hitherto unrecognized D3 transcriptional inhibitor. Finally, in a BCC mouse model, keratinocyte-specific D3 depletion markedly reduced tumor growth. Together, our results establish TH action as a critical hub of multiple oncogenic pathways and provide functional and mechanistic evidence of the involvement of TH metabolism in BCC tumorigenesis. Moreover, our results identify a miR21/GRHL3/D3 axis that reduces TH in the tumor microenvironment and has potential to be targeted as a therapeutic approach to BCC.

Authors

Daniela Di Girolamo, Raffaele Ambrosio, Maria A. De Stefano, Giuseppina Mancino, Tommaso Porcelli, Cristina Luongo, Emery Di Cicco, Giulia Scalia, Luigi Del Vecchio, Annamaria Colao, Andrzej A. Dlugosz, Caterina Missero, Domenico Salvatore, Monica Dentice

×

Figure 2

miR21 upregulates D3 expression by targeting GRHL3.

Options: View larger image (or click on image) Download as PowerPoint
miR21 upregulates D3 expression by targeting GRHL3.
(A) BCC cells were t...
(A) BCC cells were transiently transfected with miR21 expression plasmid, and cells were collected at the indicated times. D3 mRNA and protein were measured by real-time PCR and Western blot (see complete unedited blots in the supplemental material). (B) LNA anti-miR21 or a control LNA-scrambled oligo was transfected in BCC cells, and D3 mRNA and protein were measured as in A. (C) BCC cells transfected with the artificial T3-responsive promoter TRE3-TK-Luc and CMV-renilla as internal control. Increasing amounts of miR21 were cotransfected, and cells were analyzed for luciferase activity. The results are shown as means ± SD of the luciferase/renilla (LUC/Renilla) ratios from at least 3 separate experiments, performed in duplicate. (D) miR21 target genes were classified for functional classification with the DAVID program (36). (E) D3 protein levels were measured by Western blot in BCC cells transfected with Flag-GRHL3 and harvested at the indicated times. GRHL3 (anti-Flag) and tubulin levels were measured as control. (F) Primary cultures of keratinocytes were transfected with miR21, and cells were harvested at 48 and 72 hours. Dio3 and Grhl3 mRNAs were measured by real-time PCR. (G) BCC cells were transfected with 2 different siRNAs targeting endogenous Grhl3 oligos or a combination of them, and D3 protein was measured by Western blot analysis. (H) Schematic representation of the Dio3 locus, the Dio3 promoter, and the G1 site (red) responsive to GRHL. (I and J) BCC cells were transiently transfected with Dio3-Luc promoter (I) or Dio3-Luc and mutDio3-Luc promoters (J) and with increasing amounts of the GRHL3 plasmid. Cells were harvested 48 hours after transfection and analyzed for luciferase activity. CMV-renilla was cotransfected as internal control. The results are shown as means ± SD of the LUC/renilla ratios from at least 3 separate experiments, performed in duplicate. *P < 0.05.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts